SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
175 hedge funds and large institutions have $374M invested in Sage Therapeutics in 2024 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 66 increasing their positions, 51 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
36% less capital invested
Capital invested by funds: $581M → $374M (-$207M)
53% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 32
Holders
175
Holding in Top 10
–
Calls
$3.95M
Puts
$1.55M
Top Buyers
| 1 | +$9.14M | |
| 2 | +$6.83M | |
| 3 | +$3.26M | |
| 4 |
JFG
Jefferies Financial Group
New York
|
+$2.39M |
| 5 |
D.E. Shaw & Co
New York
|
+$2.33M |
Top Sellers
| 1 | -$7.57M | |
| 2 | -$5.31M | |
| 3 | -$4.74M | |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$4.34M |
| 5 |
Morgan Stanley
New York
|
-$4.2M |